Provided by Tiger Trade Technology Pte. Ltd.

Clearside Biomedical

0.4100
0.0000
Volume:- -
Turnover:1.19M
Market Cap:2.15M
PE:-0.08
High:0.4100
Open:0.4100
Low:0.4100
Close:0.4100
52wk High:17.10
52wk Low:0.3701
Shares:5.23M
Float Shares:4.54M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0452
EPS(LYR):-6.9818
ROE:-1310.02%
ROA:-70.35%
PB:-0.04
PE(LYR):-0.06

Loading ...

Clearside Biomedical Announces Reverse Stock Split Plan

TIPRANKS
·
Sep 11, 2025

BRIEF-Clearside Biomedical Files For 1-For-15 Reverse Stock Split - SEC Filing

Reuters
·
Sep 11, 2025

Clearside Biomedical Inc - Files for 1-for-15 Reverse Stock Split - SEC Filing

THOMSON REUTERS
·
Sep 11, 2025

Clearside Biomedical Announces 1-for-15 Reverse Stock Split and Share Reduction

Reuters
·
Sep 11, 2025

BRIEF-Clearside Biomedical - On Sept 4, Enters Amendment Agreement With Healthcare Royalty Partners - SEC Filing

Reuters
·
Sep 08, 2025

Clearside Biomedical Inc - Seller Receives Additional $3 Mln for Scs Microinjector Assets - SEC Filing

THOMSON REUTERS
·
Sep 08, 2025

Clearside Biomedical Secures $3 Million Agreement for SCS Microinjector Assets with Healthcare Royalty Partners

Reuters
·
Sep 08, 2025

Clearside Biomedical Inc. Conducted Special Stockholder Meeting to Address Reverse Stock Split

Reuters
·
Sep 04, 2025

Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress

GlobeNewswire
·
Aug 26, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 15, 2025

Clearside Biomedical Inc. Faces Nasdaq Delisting Due to Non-Compliance with Minimum Bid Price Rule

Reuters
·
Aug 15, 2025

Clearside Biomedical Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 12, 2025

Clearside Biomedical Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
Aug 08, 2025

Clearside Biomedical Inc. Announces Date for Special Stockholders Meeting

Reuters
·
Aug 04, 2025

Clearside Biomedical Inc. Announces Date for Special Stockholders Meeting

Reuters
·
Jul 26, 2025

BRIEF-Clearside Biomedical Announces Approval Of Xipere® Suprachoroidal Treatment For Uveitic Macular Edema In Canada

Reuters
·
Jul 23, 2025

Clearside Biomedical Shares Fall After Analyst Downgrades

MT Newswires Live
·
Jul 19, 2025

Chardan Downgrades Clearside Biomedical to Neutral From Buy, Withdraws $6 Price Target

MT Newswires Live
·
Jul 18, 2025

Clearside Biomedical Announces Plan To Explore Strategic Alternatives To Advance Its Proprietary Suprachoroidal Space (Scs®) Delivery Platform And Promising Ophthalmology Pipeline

Reuters
·
Jul 17, 2025

BRIEF-Clearside Biomedical Inc - All Employees To Transition To Consulting Roles - SEC Filing

Reuters
·
Jul 17, 2025